DAM
DMII

Deltec Asset Management’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Deltec Asset Management’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Hold
50,000
– – 0.07% 165
2026
Q1 		$499K Hold
50,000
– – 0.09% 143
2025
Q4 		$495K Buy
+50,000
New +$494K 0.08% 148

Other funds holding DMII

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MCS
Mercuria Capital Strategies Houston, Texas $163M AUM 258.7% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

Deltec Asset Management's DMII Position: Q2 2026 in Review

Deltec Asset Management held its Drugs Made In America Acquisition II Corp (DMII) position steady in Q2 2026 at 50,000 shares worth $503K. The position accounts for 0.07% of the portfolio, ranked #165.

Deltec Asset Management first reported a position in DMII in Q4 2025 and has held it in 3 quarters since. 7 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • Deltec Asset Management held 50,000 shares of Drugs Made In America Acquisition II Corp worth $503K as of Q2 2026.
  • Deltec Asset Management left its Drugs Made In America Acquisition II Corp share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition II Corp made up 0.07% of Deltec Asset Management's portfolio in Q2 2026, its #165 holding.
  • Deltec Asset Management first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 3 quarters since.
  • 7 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on Deltec Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.